The Future Is Now: How Analytics Can Solve Today’s Business Problems

Posted by Indraneel Mukherjee on December 5, 2019

“2020 will be an exciting year for us. We’ll launch a few advanced devices and solutions that will have a transformative impact on patient lives and will position us as the leading provider of care in our therapeutic area,” said a general manager of a large capital equipment manufacturer.


>
Read More

Innovation Is Healthcare’s New Normal

Posted by Pratap Khedkar on October 17, 2019

This blog post was originally published on ZS's pharma blog, The Active Ingredient.

Sometimes it’s hard to keep in mind that healthcare was once considered a stodgy, conservative industry—at least by outsiders. Advances in care development and delivery happened, but the healthcare experience was generally the same as it had been decades before, as were the business models leveraged across the healthcare landscape. We’d grown, maybe not comfortable with, but accepting of the status quo.


>
Read More

Why Forecasting in Medtech Is so Hard and What Can Be Done About It

Posted by Wenhao Xia on August 22, 2019

Sales forecasts play a critical role in the success of every company. An accurate and sufficiently granular forecast is critical for ongoing demand planning, brand strategy, investor communications, inventory and manufacturing, and many other core functions for any company.


>
Read More

Assessing the Future of Robotics in Medtech

Posted by Andy Kach on August 14, 2019

This article was originally published in Medtech Insight.

Every medical device company—in and out of the surgical business—and many other tech companies are deep in the war of surgical robotics and digital solutions.


>
Read More

AI in Medtech: Innovating in An Era of Uncertainty

Posted by Kate Templeton on July 23, 2019

This post is the second in a multi-part series on how the rules of the road are changing in medtech, and the implications on commercial strategy. Sundeep Karnik contributed to this blog post.

With the speed and impact of innovation increasing rapidly, our institutions have struggled to keep up. For better or worse, rules and regulations have typically lagged behind the innovation frontier, responding only when a crisis or particular incident highlights a new challenge to be managed or risk to be mitigated. This dynamic isn’t specific to healthcare—just think back on all of the questions raised in the last few years with Tesla’s autopilot car crashes to see the parallels. Regardless of industry, for those innovators on the cutting edge, this creates an environment of regulatory uncertainly that is inherently risky for the companies that blaze forward assuming a specific regulatory approach will be adopted by the relevant authorities. The more disruptive the technology, the more likely it is that such an environment will exist.


>
Read More